11.01.02
As the nutraceuticals industry closes the door on another rough year and looks ahead, most executives are of the opinion that we have our work cut out for us. However, there are some bright spots in some cases and many executives are positive about the future of their business as well as the industry itself. What follows is commentary from executives throughout the industry on the year that has passed and the year ahead.
"Regarding the state of the industry in Japan, the overview comments made one year ago are unfortunately still valid, with the continuing depressed economy the dominant problem. Nevertheless, the nutraceuticals and functional foods markets are growing in spite of the economic problems, and in spite of recent food safety incidents (more 'mad cows', adulterated weight loss products from China, intentionally misbranded foods, etc.), which are causing serious consumer concerns. It is possible, however, that the credibility of the FOSHU (Foods for Specified Health Uses) category of functional foods with health claims will actually be enhanced by these crises, improving the already positive image of the category and resulting in additional growth in the f
"Regarding the state of the industry in Japan, the overview comments made one year ago are unfortunately still valid, with the continuing depressed economy the dominant problem. Nevertheless, the nutraceuticals and functional foods markets are growing in spite of the economic problems, and in spite of recent food safety incidents (more 'mad cows', adulterated weight loss products from China, intentionally misbranded foods, etc.), which are causing serious consumer concerns. It is possible, however, that the credibility of the FOSHU (Foods for Specified Health Uses) category of functional foods with health claims will actually be enhanced by these crises, improving the already positive image of the category and resulting in additional growth in the f
Continue reading this story and get 24/7 access to Nutraceuticals World for FREE
FREE SUBSCRIPTION
